High doses of PUFAs didn't differentially affect lean tissue accumulation in middle-aged individuals with overweight, as in the elderly and young lean populations.
An updated guideline on the management of Sjögren disease has been produced by the British Society for Rheumatology, providing practical advice for healthcare professionals and the people they treat.